AI CuratorAI-generated
Research summary · AI summary · not yet reviewedSubjects not reportedNot reportedPeer review unconfirmed
Glymphatic Dysfunction in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
A study involving 196 MS patients found that they had more significant glymphatic-related impairment compared to NMOSD patients and healthy controls. Key metrics, DTI-ALPS and PVeD, were significantly reduced in MS (p<0.001).
- Tags
- #MSResearch
- Most relevant to
- —
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Why it matters
These findings suggest potential differences in glymphatic function between MS and NMOSD, which could inform future research on disease mechanisms and treatment.
What this does not prove
The study does not establish causal relationships between glymphatic dysfunction and clinical outcomes. More longitudinal and mechanistic studies are needed to better understand these findings.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- 196 · 196 MS patients were enrolled in the study.
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-09-18
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
- Primary evidenceDisease-specific patterns of glymphatic-related dysfunction between multiple sclerosis and neuromyelitis optica spectrum disorder. ↗DOI: 10.3389/fimmu.2026.1917373
Supporting passages (6)
sample sizeMETHODS: This study enrolled 196 MS patients, 88 NMOSD patients, and 108 healthy controls (HC).
sample size basisMETHODS: This study enrolled 196 MS patients, 88 NMOSD patients, and 108 healthy controls (HC).
publication datePublication date: 2026-09-18
comparatorMETHODS: This study enrolled 196 MS patients, 88 NMOSD patients, and 108 healthy controls (HC).
findingsRESULTS: MS showed more extensive glymphatic-related impairment than NMOSD, with significant reductions in both DTI-ALPS and PVeD compared to HC (all p<0.001).
limitationsTitle: Disease-specific patterns of glymphatic-related dysfunction between multiple sclerosis and neuromyelitis optica spectrum disorder.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.